Suppr超能文献

验证法语版自我管理国际髋关节结局工具 12 问卷,并确定法语人群中的最小临床重要差异 (MCID)。

Validation of the French version of the Self-Administered International Hip Outcome Tool-12 Questionnaire and determination of the Minimal Clinically Important Difference (MCID) in the French speaking population.

机构信息

Département de Chirurgie Orthopédique, CHU de Québec-Hôpital de l'Enfant-Jésus, 1401 18e Rue, Québec, Québec, G1J 1Z4, Canada.

Centre de recherche clinique et évaluative, CHU de Québec, 2705 Boulevard Laurier, Québec, Québec, G1V 4G2, Canada.

出版信息

Orthop Traumatol Surg Res. 2021 Dec;107(8):103083. doi: 10.1016/j.otsr.2021.103083. Epub 2021 Oct 1.

Abstract

BACKGROUND

Patient-Reported Outcomes tools are becoming the gold standard in the evaluation of results in orthopaedic surgery. In 2012, the International Hip Outcome Tool-12 (iHOT-12) was developed. This self-administered questionnaire was designed to address the day-to-day clinical setting with faster completion and easier patient flow. In 2021, a French translation of the iHOT-33 questionnaire, from which the iHOT-12 is derived, proved to be valid. Since there is not data in French regarding iHOT-12, we performed a prospective study aiming to answer: (1) is this French version of the iHOT-12 questionnaire as valid, (2) can the minimal clinically important difference (MCID) value for patients undergoing hip arthroscopy for femoro-acetabular impingement (FAI) be defined?

HYPOTHESIS

It is hypothesized that the iHOT-12-Fr would be valid and responsive to change in a cohort treated for FAI.

PATIENTS AND METHODS

Using the COSMIN recommendations, a multicentric prospective cohort study was conducted to evaluate the reliability, validity, responsiveness and MCID of the iHOT-12-Fr.

RESULTS

In total, 101 patients were recruited for participation in the project. The reliability of the iHOT-12-Fr questionnaire was assessed with the intraclass correlation coefficient (ICC=0.84) and the internal consistency with a Cronbach's alpha (α=0.86). The standard error of measurement (SEM=6.7) and the smallest detectable change (SDC=1.8) were calculated. Construct validity was evaluated with Pearson's correlation coefficients (r) by comparing the iHOT-12-Fr with the iHOT-33-Fr (r=0.96), the Hip disability and Osteoarthritis Outcome Score-Fr (r=0.68) and Nonarthritic Hip Score-Fr (r=0.82). Responsiveness was shown with a standardized effect size of 1.18, standardized response mean of 0.73, responsiveness ratio of 1.4 and an MCID of 11 points.

DISCUSSION

Metrological qualities of the iHOT-12-Fr are comparable to the original version and other versions translated into different languages. This study proves that the French translation of the iHOT-12 is valid, reliable and compares to the original iHOT-12.

LEVEL OF EVIDENCE

IV prospective study.

摘要

背景

患者报告的结果工具正在成为评估矫形外科手术结果的金标准。2012 年,国际髋关节结果工具-12(iHOT-12)应运而生。该自我管理问卷旨在通过更快的完成和更简单的患者流程来解决日常临床环境中的问题。2021 年,源自 iHOT-33 问卷的 iHOT-12 的法语翻译被证明是有效的。由于法语中没有关于 iHOT-12 的数据,我们进行了一项前瞻性研究,旨在回答:(1)该 iHOT-12 问卷的法语版本是否有效,(2)是否可以定义髋关节镜治疗股骨髋臼撞击症(FAI)患者的最小临床重要差异(MCID)值?

假设

假设 iHOT-12-Fr 在接受 FAI 治疗的患者中是有效的和有反应的。

患者和方法

使用 COSMIN 建议,进行了一项多中心前瞻性队列研究,以评估 iHOT-12-Fr 的可靠性、有效性、反应性和 MCID。

结果

共有 101 名患者参与了该项目。使用组内相关系数(ICC=0.84)评估 iHOT-12-Fr 问卷的可靠性,使用 Cronbach's alpha(α=0.86)评估内部一致性。计算出测量标准误差(SEM=6.7)和最小可检测变化(SDC=1.8)。通过与 iHOT-33-Fr(r=0.96)、髋关节残疾和骨关节炎结果评分-Fr(r=0.68)和非关节炎髋关节评分-Fr(r=0.82)进行 Pearson 相关系数(r)比较,评估结构效度。反应性通过标准化效应量为 1.18、标准化反应均值为 0.73、反应比为 1.4 和 MCID 为 11 分来表示。

讨论

iHOT-12-Fr 的计量学质量与原始版本和其他翻译成不同语言的版本相当。本研究证明了 iHOT-12 的法语翻译是有效的、可靠的,并与原始的 iHOT-12 进行了比较。

证据水平

IV 项前瞻性研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验